Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
Pennsylvania Governor Tom Wolf Announces Executive Action on Workers' Compensation Opioids
On Thursday, April 26, 2018, Governor Wolf announced he will initiate an executive action to address the misuse and overprescribing of opioids in t
Workers' Comp
Article
StateWatch: Bill Review April 2018
Keep current with new legislation and its potential effect on your organization.
Mitchell
Article
Everyday Insurance Analytics: Using Data at Every Level
Data analytics have now permeated most levels of insurance company organizations, creating exciting new opportunities but also some interesting cha
Mitchell
News Release
Mitchell Secures New Investment Partner in Stone Point Capital in its Continued Commitment to Growth and Innovation
SAN DIEGO and NEW YORK—April 26th, 2018—Mitchell International, Inc. (Mitchell), a leading provider of technology,
Mitchell
Article
Diagnostics Systems Key to Proper and Safe Repairs for Fountain Valley Body Shop
Since opening his Fountain Valley body shop over 40 years ago, owner Dave March has had a front row seat witnessing the evolution of the collision
Mitchell
News Release
Pennsylvania House Passes Drug Formulary Bill
By Brian Allen, VP of Government Affairs